BioMed Research International / 2009 / Article / Fig 4

Methodology Report

Methyl-CpG-Binding PCR of Bloodspots for Confirmation of Fragile X Syndrome in Males

Figure 4

Detection sensitivity of MB-PCR. (a) MB-PCR analysis using different amounts of input DNA, cycle numbers of the PCR amplification, and NaCl concentration in the stringency washes. (b) MB-PCR analysis of the DNA samples simulated as mosaic FXS by mixing 0.5 ng of DNA sample from an FXS male with varying amounts of DNA sample from a non-FXS male. (–): Control DNA with universally unmethylated sequences; (+): control DNA with universally methylated sequences; (M): molecular-size markers.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.